Converted neural cells: induced to a cure?
10.1007/s13238-012-2029-2
- Author:
Weiqi ZHANG
1
;
Shunlei DUAN
;
Ying LI
;
Xiuling XU
;
Jing QU
;
Weizhou ZHANG
;
Guang-Hui LIU
Author Information
1. National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
- Publication Type:Journal Article
- MeSH:
Amyotrophic Lateral Sclerosis;
therapy;
Animals;
Cell Transdifferentiation;
Cell- and Tissue-Based Therapy;
Induced Pluripotent Stem Cells;
cytology;
Neurons;
cytology;
transplantation;
Parkinson Disease;
therapy;
Stroke;
therapy
- From:
Protein & Cell
2012;3(2):91-97
- CountryChina
- Language:English
-
Abstract:
Many neurodegenerative disorders such as Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and others often occur as a result of progressive loss of structure or function of neurons. Recently, many groups were able to generate neural cells, either differentiated from induced pluripotent stem cells (iPSCs) or converted from somatic cells. Advances in converted neural cells have opened a new era to ease applications for modeling diseases and screening drugs. In addition, the converted neural cells also hold the promise for cell replacement therapy (Kikuchi et al., 2011; Krencik et al., 2011; Kriks et al., 2011; Nori et al., 2011; Rhee et al., 2011; Schwartz et al., 2012). Here we will mainly discuss most recent progress on using converted functional neural cells to treat neurological diseases and highlight potential clinical challenges and future perspectives.
